1-3 of 3
Juan Luis García, PhD
Close
Sort by
Journal Articles

CRISPR/Cas9-Generated Models Uncover Therapeutic Vulnerabilities of Del(11q) Chronic Lymphocytic Leukemia Cells to Dual BCR and PARP Inhibition

Miguel Quijada Álamo, BSc, MSc, María Hernández-Sánchez, PhD, José Luis Ordóñez, PhD, Verónica Alonso Pérez, PhD, Ana E. Rodriguez, PhD, Ignacio García-Tuñón, PhD, Ana B Herrero, PhD, Laura San-Segundo, Michaela Gruber, MD PhD, Juan Luis García, PhD, Rocio Benito, PhD, Catherine J. Wu, MD, Jesús-María Hernández-Rivas, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 948.
https://doi.org/10.1182/blood-2018-99-116080
Published: 2018
Journal Articles

Post-Transcriptional Modifications Explain the Overexpression of CCND2 in Multiple Myeloma

Irena Misiewicz-Krzeminska, PhD, Maria Eugenia Sarasquete, PhD, Carolina Vicente-Dueñas, PhD, Patryk Krzeminski, PhD, Katarzyna Wiktorska, PhD, Dalia Quwaider, Elizabeta A. Rojas, Rocío Corral, Luis Antonio Corchete, Ana A. Martin, MD, Fernando Escalante, Abelardo Bárez, Juan Luis Garcia, PhD, Isidro Sanchez-Garcia, MD PhD, Ramón García-Sanz, MD PhD, Jesus F. San Miguel, Norma Carmen Gutierrez, PhD MD
Journal: Blood
Blood (2014) 124 (21): 2001.
https://doi.org/10.1182/blood.V124.21.2001.2001
Published: 2014
Journal Articles

Imatinib Mesilate Modifies Genes Involved in Hematopoiesis in Non Clonal Bone Marrow Cells from CML Patients in Complete Cytogenetic Response.

Fermin M. Sanchez-Guijo, MD, PhD, Eva Lumbreras, BSc, Patricia Morais, BSc, Juan-Luis Garcia, PhD, Norma C. Gutierrez, MD, PhD, J.F. San Miguel, MD, PhD, Consuelo del Canizo, MD, PhD, Jesus M. Hernandez-Rivas, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2947.
https://doi.org/10.1182/blood.V110.11.2947.2947
Published: 2007